Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds

Yan Shi1, Caroline Desponts, Jeong Tae Do

  • 1Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.

Cell Stem Cell
|November 6, 2008
PubMed

Insights

Researchers developed a small-molecule combination to improve induced pluripotent stem cell (iPSC) generation. This approach enhances reprogramming efficiency without needing all critical viral factors, advancing cell therapy research.

Area of Science:

  • Stem Cell Biology
  • Molecular Biology
  • Biotechnology

Background:

  • Induced pluripotent stem cells (iPSCs) are generated using transcription factors like Oct4, Sox2, Klf4, and c-Myc.
  • Current methods face challenges with efficiency and viral integration, limiting therapeutic applications.
  • Neural progenitor cells (NPCs) can be reprogrammed using Oct4/Klf4, potentially due to endogenous Sox2 expression.

Purpose of the Study:

  • To identify alternative methods for efficient iPSC generation.
  • To find small molecules that can compensate for essential reprogramming factors.
  • To improve the therapeutic relevance of iPSC technology.

Main Methods:

  • Phenotypic screening for small molecules.
  • Testing a combination of BIX-01294 and BayK8644.
  • Reprogramming Oct4/Klf4-transduced mouse embryonic fibroblasts.

Main Results:

  • A small-molecule combination (BIX-01294 and BayK8644) was identified.
  • These molecules enabled reprogramming of mouse embryonic fibroblasts lacking essential endogenous factors.
  • Small molecules compensated for viral transduction of factors like Sox2, enhancing reprogramming efficiency.

Conclusions:

  • Small molecules can substitute for viral transduction of critical reprogramming factors.
  • This strategy improves the efficiency of induced pluripotent stem cell generation.
  • The findings offer a more therapeutically viable approach to iPSC technology.

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...